133 related articles for article (PubMed ID: 28890177)
1. Lignanamides with potent antihyperlipidemic activities from the root bark of Lycium chinense.
Chen H; Li YJ; Sun YJ; Gong JH; Du K; Zhang YL; Su CF; Han QQ; Zheng XK; Feng WS
Fitoterapia; 2017 Oct; 122():119-125. PubMed ID: 28890177
[TBL] [Abstract][Full Text] [Related]
2. Antihyperlipidemic glycosides from the root bark of
Chen H; Li YJ; Sun YJ; Li XK; Jian-Hong G; Wu Y; Su FY; Du K; Zhang YL; Feng WS
Nat Prod Res; 2019 Sep; 33(18):2655-2661. PubMed ID: 29737867
[TBL] [Abstract][Full Text] [Related]
3. A new furolactone-type lignan from Lycium chinense.
Li XN; Chu C; Tong SQ; Cheng DP; Yan JZ
Nat Prod Res; 2013 Apr; 27(8):750-2. PubMed ID: 22720714
[TBL] [Abstract][Full Text] [Related]
4. New long-chain hydroxyalkyl ferulates from the root bark of Lycium chinense Mill.
Pan S; Hou AJ
J Asian Nat Prod Res; 2009 Jul; 11(7):681-5. PubMed ID: 20183307
[TBL] [Abstract][Full Text] [Related]
5. Bioactive Octahydroxylated C21 Steroids from the Root Bark of Lycium chinense.
An YW; Zhan ZL; Xie J; Yang YN; Jiang JS; Feng ZM; Ye F; Zhang PC
J Nat Prod; 2016 Apr; 79(4):1024-34. PubMed ID: 26982999
[TBL] [Abstract][Full Text] [Related]
6. Four new diastereoisomeric neolignan glycosides from the root bark of Lycium chinense Miller. and their α-glucosidase inhibitory activity.
Duan YD; Su CY; Liang Y; Su YY; Zhu LL; Zhang W; Liu B
Fitoterapia; 2023 Jul; 168():105520. PubMed ID: 37121406
[TBL] [Abstract][Full Text] [Related]
7. Neolignanamides, lignanamides, and other phenolic compounds from the root bark of Lycium chinense.
Zhang JX; Guan SH; Feng RH; Wang Y; Wu ZY; Zhang YB; Chen XH; Bi KS; Guo DA
J Nat Prod; 2013 Jan; 76(1):51-8. PubMed ID: 23282106
[TBL] [Abstract][Full Text] [Related]
8. Three new lignanamides from the root of
Chen F; Huang XJ; Liang QP; Huang YP; Lan T; Zhou GX
Nat Prod Res; 2019 Dec; 33(23):3378-3382. PubMed ID: 29848098
[TBL] [Abstract][Full Text] [Related]
9. A New Lignanamide from the Root of Lycium yunnanense Kuang and Its Antioxidant Activity.
Zheng XH; Huang YP; Liang QP; Xu W; Lan T; Zhou GX
Molecules; 2018 Mar; 23(4):. PubMed ID: 29584684
[TBL] [Abstract][Full Text] [Related]
10. Activity-guided isolation of NF-κB inhibitors and PPARγ agonists from the root bark of Lycium chinense Miller.
Xie LW; Atanasov AG; Guo DA; Malainer C; Zhang JX; Zehl M; Guan SH; Heiss EH; Urban E; Dirsch VM; Kopp B
J Ethnopharmacol; 2014 Mar; 152(3):470-7. PubMed ID: 24512737
[TBL] [Abstract][Full Text] [Related]
11. Chartarlactams A-P, phenylspirodrimanes from the sponge-associated fungus Stachybotrys chartarum with antihyperlipidemic activities.
Li Y; Wu C; Liu D; Proksch P; Guo P; Lin W
J Nat Prod; 2014 Jan; 77(1):138-47. PubMed ID: 24387683
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and cytotoxic lignans from the roots of Bupleurum chinense.
Li DQ; Wang D; Zhou L; Li LZ; Liu QB; Wu YY; Yang JY; Song SJ; Wu CF
J Asian Nat Prod Res; 2017 May; 19(5):519-527. PubMed ID: 27649745
[TBL] [Abstract][Full Text] [Related]
13. A new phenolic amide from Lycium chinense Miller.
Han SH; Lee HH; Lee IS; Moon YH; Woo ER
Arch Pharm Res; 2002 Aug; 25(4):433-7. PubMed ID: 12214850
[TBL] [Abstract][Full Text] [Related]
14. Neolignans and flavonoids from the root bark of Illicium henryi.
Xiang WJ; Ma L; Hu LH
Fitoterapia; 2010 Dec; 81(8):1228-31. PubMed ID: 20727951
[TBL] [Abstract][Full Text] [Related]
15. Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity.
Potterat O
Planta Med; 2010 Jan; 76(1):7-19. PubMed ID: 19844860
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidative, anti-secretory and anti-inflammatory activities of the extract from the root bark of Lycium chinense (Cortex Lycii) against gastric ulcer in mice.
Chen H; Olatunji OJ; Zhou Y
J Nat Med; 2016 Jul; 70(3):610-9. PubMed ID: 26972100
[TBL] [Abstract][Full Text] [Related]
17. Chemical constituents from Solidago canadensis with hypolipidemic effects in HFD-fed hamsters.
Huang Y; Hao YL; Mai XY
J Asian Nat Prod Res; 2013; 15(4):319-24. PubMed ID: 23600612
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus lignans from the root of Streblus asper.
Li J; Meng AP; Guan XL; Li J; Wu Q; Deng SP; Su XJ; Yang RY
Bioorg Med Chem Lett; 2013 Apr; 23(7):2238-44. PubMed ID: 23434030
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory lignanamides from the roots of Solanum melongena L.
Sun J; Gu YF; Su XQ; Li MM; Huo HX; Zhang J; Zeng KW; Zhang Q; Zhao YF; Li J; Tu PF
Fitoterapia; 2014 Oct; 98():110-6. PubMed ID: 25068200
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial property of (+)-lyoniresinol-3alpha-O-beta-D-glucopyranoside isolated from the root bark of Lycium chinense Miller against human pathogenic microorganisms.
Lee DG; Jung HJ; Woo ER
Arch Pharm Res; 2005 Sep; 28(9):1031-6. PubMed ID: 16212233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
